ADIM
CRDO icon

Alpha DNA Investment Management’s Credo Technology Group CRDO Stock Holding History

Alpha DNA Investment Management’s Portfolio CRDO Stock Details CRDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,948
Closed -$467K – 50
2024
Q4 		$467K Buy
+6,948
New +$345K 0.18% 122

Other funds holding CRDO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Alpha DNA Investment Management's CRDO Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Credo Technology Group (CRDO) in Q1 2025, closing a stake of 6,948 shares — an estimated $467K sold.

Alpha DNA Investment Management first reported a position in CRDO in Q4 2024 and held it in 1 quarter. The position peaked at $467K in Q4 2024. 419 funds tracked by Wall St. Rank hold CRDO as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Credo Technology Group position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 6,948 Credo Technology Group shares in Q1 2025, an estimated $467K.
  • Alpha DNA Investment Management first reported a position in Credo Technology Group in Q4 2024 and held it in 1 quarter.
  • Alpha DNA Investment Management's Credo Technology Group position peaked at $467K in Q4 2024.
  • 419 funds tracked by Wall St. Rank held Credo Technology Group as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.